Discordance of self-report and laboratory measures of hiv viral load among young men who have sex with men and transgender women in chicago

Implications for epidemiology, care, and prevention

Brian Mustanski*, Daniel T. Ryan, Thomas A. Remble, Richard Thomas D'Aquila, Michael Newcomb, Ethan Morgan

*Corresponding author for this work

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Suppressing HIV viral load through daily antiretroviral therapy (ART) substantially reduces the risk of HIV transmission, however, the potential population impact of treatment as prevention (TasP) is mitigated due to challenges with sustained care engagement and ART adherence. For an undetectable viral load (VL) to inform decision making about transmission risk, individuals must be able to accurately classify their VL as detectable or undetectable. Participants were 205 HIV-infected young men who have sex with men (YMSM) and transgender women (TGW) from a large cohort study in the Chicago area. Analyses examined correspondence among self-reported undetectable VL, study-specific VL, and most recent medical record VL. Among HIV-positive YMSM/TGW, 54% had an undetectable VL (< 200 copies/mL) via study-specific laboratory testing. Concordance between self-report and medical record VL values was 80% and between self-report and study-specific laboratory testing was 73%; 34% of participants with a detectable study-specific VL self-reported an undetectable VL at last medical visit, and another 28% reported not knowing their VL status. Periods of lapsed viral suppression between medical visits may represent a particular risk for the TasP strategy among YMSM/TGW. Strategies for frequent viral load monitoring, that are not burdensome to patients, may be necessary to optimize TasP.

Original languageEnglish (US)
Pages (from-to):2360-2367
JournalAIDS and behavior
Volume22
Issue number7
DOIs
StatePublished - Jul 1 2018

Fingerprint

Transgender Persons
Viral Load
Self Report
Epidemiology
HIV
Medical Records
Therapeutics

Keywords

  • Medical records
  • Treatment as prevention
  • Undetectable
  • Viral load
  • Young msm

ASJC Scopus subject areas

  • Social Psychology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

@article{c3217a45c00b4e729403b28974c73c65,
title = "Discordance of self-report and laboratory measures of hiv viral load among young men who have sex with men and transgender women in chicago: Implications for epidemiology, care, and prevention",
abstract = "Suppressing HIV viral load through daily antiretroviral therapy (ART) substantially reduces the risk of HIV transmission, however, the potential population impact of treatment as prevention (TasP) is mitigated due to challenges with sustained care engagement and ART adherence. For an undetectable viral load (VL) to inform decision making about transmission risk, individuals must be able to accurately classify their VL as detectable or undetectable. Participants were 205 HIV-infected young men who have sex with men (YMSM) and transgender women (TGW) from a large cohort study in the Chicago area. Analyses examined correspondence among self-reported undetectable VL, study-specific VL, and most recent medical record VL. Among HIV-positive YMSM/TGW, 54{\%} had an undetectable VL (< 200 copies/mL) via study-specific laboratory testing. Concordance between self-report and medical record VL values was 80{\%} and between self-report and study-specific laboratory testing was 73{\%}; 34{\%} of participants with a detectable study-specific VL self-reported an undetectable VL at last medical visit, and another 28{\%} reported not knowing their VL status. Periods of lapsed viral suppression between medical visits may represent a particular risk for the TasP strategy among YMSM/TGW. Strategies for frequent viral load monitoring, that are not burdensome to patients, may be necessary to optimize TasP.",
keywords = "Medical records, Treatment as prevention, Undetectable, Viral load, Young msm",
author = "Brian Mustanski and Ryan, {Daniel T.} and Remble, {Thomas A.} and D'Aquila, {Richard Thomas} and Michael Newcomb and Ethan Morgan",
year = "2018",
month = "7",
day = "1",
doi = "10.1007/s10461-018-2112-7",
language = "English (US)",
volume = "22",
pages = ":2360--2367",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",
number = "7",

}

TY - JOUR

T1 - Discordance of self-report and laboratory measures of hiv viral load among young men who have sex with men and transgender women in chicago

T2 - Implications for epidemiology, care, and prevention

AU - Mustanski, Brian

AU - Ryan, Daniel T.

AU - Remble, Thomas A.

AU - D'Aquila, Richard Thomas

AU - Newcomb, Michael

AU - Morgan, Ethan

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Suppressing HIV viral load through daily antiretroviral therapy (ART) substantially reduces the risk of HIV transmission, however, the potential population impact of treatment as prevention (TasP) is mitigated due to challenges with sustained care engagement and ART adherence. For an undetectable viral load (VL) to inform decision making about transmission risk, individuals must be able to accurately classify their VL as detectable or undetectable. Participants were 205 HIV-infected young men who have sex with men (YMSM) and transgender women (TGW) from a large cohort study in the Chicago area. Analyses examined correspondence among self-reported undetectable VL, study-specific VL, and most recent medical record VL. Among HIV-positive YMSM/TGW, 54% had an undetectable VL (< 200 copies/mL) via study-specific laboratory testing. Concordance between self-report and medical record VL values was 80% and between self-report and study-specific laboratory testing was 73%; 34% of participants with a detectable study-specific VL self-reported an undetectable VL at last medical visit, and another 28% reported not knowing their VL status. Periods of lapsed viral suppression between medical visits may represent a particular risk for the TasP strategy among YMSM/TGW. Strategies for frequent viral load monitoring, that are not burdensome to patients, may be necessary to optimize TasP.

AB - Suppressing HIV viral load through daily antiretroviral therapy (ART) substantially reduces the risk of HIV transmission, however, the potential population impact of treatment as prevention (TasP) is mitigated due to challenges with sustained care engagement and ART adherence. For an undetectable viral load (VL) to inform decision making about transmission risk, individuals must be able to accurately classify their VL as detectable or undetectable. Participants were 205 HIV-infected young men who have sex with men (YMSM) and transgender women (TGW) from a large cohort study in the Chicago area. Analyses examined correspondence among self-reported undetectable VL, study-specific VL, and most recent medical record VL. Among HIV-positive YMSM/TGW, 54% had an undetectable VL (< 200 copies/mL) via study-specific laboratory testing. Concordance between self-report and medical record VL values was 80% and between self-report and study-specific laboratory testing was 73%; 34% of participants with a detectable study-specific VL self-reported an undetectable VL at last medical visit, and another 28% reported not knowing their VL status. Periods of lapsed viral suppression between medical visits may represent a particular risk for the TasP strategy among YMSM/TGW. Strategies for frequent viral load monitoring, that are not burdensome to patients, may be necessary to optimize TasP.

KW - Medical records

KW - Treatment as prevention

KW - Undetectable

KW - Viral load

KW - Young msm

UR - http://www.scopus.com/inward/record.url?scp=85045155064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045155064&partnerID=8YFLogxK

U2 - 10.1007/s10461-018-2112-7

DO - 10.1007/s10461-018-2112-7

M3 - Article

VL - 22

SP - :2360-2367

JO - AIDS and Behavior

JF - AIDS and Behavior

SN - 1090-7165

IS - 7

ER -